Dr. Camargo is an Assistant Professor of Clinical Medicine, Immunocompromised Host Section, Division of Infectious Diseases at the University of Miami, Miller School of Medicine; and Staff Physician at the Infectious Diseases clinics of the Miami Transplant Institute and the Sylvester Comprehensive Cancer Center, Miami, Florida. He completed Internal Medicine training at Albert Einstein College of Medicine and Infectious Disease fellowship at New York Medical College. He is also a former graduate of the Transplant Infectious Diseases fellowship program at the University of Toronto Health Network. His current research is focused on identification of immune biomarkers to predict clinical outcomes in transplant recipients.

Lara Danziger-Isakov is the Director of Pediatric Immunocompromised Host Infectious Diseases and Professor of Pediatrics at Cincinnati Children’s Hospital Medical Center. She earned her MD at Case Western Reserve University School of Medicine, completed residency at the Cleveland Clinic and a fellowship in Pediatric Infectious Diseases at St. Louis Children's Hospital and Washington University. Her clinical interests include pediatric infectious diseases, infections in transplant recipients, and infections in immunocompromised patients. Her research interests include outcomes related to infection after pediatric transplantation with an emphasis on pediatric solid organ transplantation and hematopoietic stem cell transplantation.

Dr. Feld completed clinical training at the University of Toronto in gasteroenterology and hepatoplogy, followed by a research fellowship in the Liver Diseases Branch at the National Institutes of Health. He also completed a Masters of Public Health at the Johns Hopkins Bloomberg School of Public Health. Dr Feld currently holds the R. Phelan Chair in Translational Liver Disease Research and is a Clinician Scientist and Associate Professor of Medicine at the University Health Network, University of Toronto where he leads a large clinical and laboratory based research program on therapeutics and immunological aspects of viral hepatitis infections.

Atul Humar is a Professor in the Department of Medicine, University of Toronto. Dr. Humar received his medical degree from the University of Ottawa. He completed his residency and did further training in Transplant Infectious Diseases in Toronto and Boston. Dr. Humar’s research interests are in virology with a focus on the pathogenesis of herpesvirus infections post-transplant. He is involved in both basic and clinical research assessing immunologic and virologic determinants of infection. Dr. Humar is the Director of Multi Organ Transplant Program at the University Health Network and the University of Toronto Transplant Institute. He is now the Past-President of the Canadian Society of Transplantation (CST). He was elected to President of the CST in October 2015. In May 2018, he became a Fellow of the American Society for Transplantation (FAST).

Dr. Husain is an internationally recognized expert in the field of Transplant Infectious Diseases. He has served as Chairman of the Infectious Diseases Council, of the International Society of Heart and Lung Transplantation, and is actively involved with other professional societies. Dr. Husain’s research has focused on the risk factors and outcomes of infections in solid organ transplant recipients. He has special interest in antibiotic stewardship of immunocompromised hosts. To date, Dr. Husain has published more than 100 peer reviewed publications and has authored more than 5 book chapters. He also serves as a reviewer in various journals.

Greg Knoll is Head of the Division of Nephrology at the Ottawa Hospital and Professor of Medicine at the University of Ottawa. He currently holds the University of Ottawa Chair in Clinical Transplantation Research and is a Senior Scientist with the Clinical Epidemiology Program of the Ottawa Hospital Research Institute. He is a Past-President of the Canadian Society of Transplantation. He is involved in ongoing studies related to the measurement of renal function in kidney transplant recipients, cardiac screening in kidney transplant candidates, systematic reviews on immunosuppressive strategies, and measuring quality in transplantation. He is the Co-Chair of the international KDIGO guidelines on the Evaluation and Management of Candidates for Kidney Transplantation.

Dr. Kumar is Professor of Medicine at University of Toronto and Staff Physician at the University Health Network. She has a translational research program that consists of both clinical and laboratory-based research. Her research focuses on immunologic responses to vaccines and viral infections in transplant recipients. She has supervised numerous graduate students and medical residents/fellows. She has authored over 100 manuscripts, editorials, and book chapters in the field of transplantation. For her research she has been a recipient of the AST Clinical Investigator Award and the Royal College Gold Medal in Medicine. She has held leadership positions in both the CST and AST. She is Editor-in-chief of The AST Handbook of Transplant Infections and Associate Editor of the 4th Transplant ID Guidelines.

Me-Linh Luong, is an assistant professor of Medicine at the University of Montreal, Canada. Dr. Luong earned her MD at the University of Sherbrooke, completed her residency training in Infectious Diseases and Medical microbiology program at McGill University and received her postgraduate training in Transplant Infectious Diseases at the University of Toronto. Her research interests include novel diagnostics methods for fungal infections, epidemiology and outcome of fungal infection in lung transplant recipients, and antifungal treatment.

Dr. Marras is the Director of the Toronto Western Hospital Nontuberculous Mycobacterial Disease Program, a consultant in Respirology at University Health Network, a staff physician at the Toronto Western Hospital TB Clinic, and an Associate Professor of Medicine at University of Toronto. He received his M.D. at Queen's University, clinical training in Internal Medicine and Respirology (FRCPC) at UofT, and M.Sc. in Clinical Epidemiology at UofT. He took advanced training in mycobacterial diseases at University of California, San Francisco, Stanford University, Palo Alto, California, and National Jewish Health, Denver Colorado. His clinical and research focus is in the field of nontuberculous mycobacterial disease.

Dr. Robin Patel graduated from Princeton University with a BA in Chemistry and from McGill University with an M.D. She completed a residency in Internal Medicine and fellowships in Infectious Diseases and Microbiology at Mayo Clinic. She is the Elizabeth P. and Robert E. Allen Professor of Individualized Medicine, Professor of Medicine, Professor of Microbiology, Chair of the Division of Clinical Microbiology, and Director of the Infectious Diseases Research Laboratory at Mayo Clinic. Dr. Patel is a Fellow of American Academy of Microbiology, co-chair of the ASM Microbe Program Planning Committee, President Elect Elect of ASM, an associate editor for the Journal of Clinical Microbiology and Clinical Infectious Diseases, and course director for the Mayo Medical School Microbiology course. Her research focuses on clinical bacteriology diagnostic testing, antimicrobial resistance, and microbial biofilms.

Dr. Rotstein is Professor of Medicine in the Division of Infectious Diseases at the University of Toronto and an Attending Physician for the Immunocompromised Host He received a Bachelor of Science at the University of Toronto and earned his medical degree from the University of Calgary in 1976. Dr. Rotstein completed his specialty training in Internal Medicine at the University of Toronto and pursued further subspecialty training in Infectious Diseases & Immunology at the Medical University of South Carolina in Charleston, South Carolina from 1980 to 1983 [ABIM (1980), FRCPC (Internal Medicine 1981), Infectious Diseases ABIM (1982)]. Dr. Rotstein is currently the Director of Oncologic Infectious Diseases of the Immunocompromised Host Infectious Diseases Service at the UHN. He is also former Director of the Division of Infectious Diseases at McMaster University. Dr. Rotstein has published over 160 peer-reviewed papers and his research interests have focused mainly on infections in cancer patients and other immunocompromised hosts as well as fungal infections caused by Candida organisms.

Nina Singh, is a tenured Professor of Medicine at the University of Pittsburgh, and the Chief of Transplant infectious Diseases at the Pittsburgh VA Healthcare System. She has a dedicated career in the field of transplant infectious diseases. Her primary areas of research interests include cytomegalovirus and opportunistic mycoses, in particular cryptococcosis and invasive aspergillosis in organ transplant recipients. She has authored over 300 peer reviewed publications, 25 book chapters and edited 2 books on transplant infectious diseases. She is the senior author of the most cited paper in immunology and the first author of paper cited in top 1% in Infectious Diseases per ISI and ESI . She is the three time recipient of Pfizer National Visiting Professorship Award in Infectious Diseases and has been listed as Best Doctors in America, Who’s Who in Medicine and as America’s Top Physicians, Consumer Research Council of America. She has served on the study sections of the NIH and the Canadian Institute of Health Research. She has served on the on the editorial board of Transplantation and as Associate Editor for Liver Transplantation.